This is a Validated Antibody Database (VAD) review about mouse Araf, based on 5 published articles (read how Labome selects the articles), using Araf antibody in all methods. It is aimed to help Labome visitors find the most suited Araf antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Araf synonym: 1200013E08Rik; A-Raf; AW495444; Araf1; serine/threonine-protein kinase A-Raf; A-Raf proto-oncogene serine/threonine-protein kinase; proto-oncogene A-Raf; raf-related oncogene; v-raf murine sarcoma 3611 viral oncogene homolog 1
Santa Cruz Biotechnology
mouse monoclonal (1) |
| In order to clarify the interaction of SPRED1 with Ras and Raf, Santa Cruz Biotechnology Araf antibody (Santa Cruz, sc-135820) was used in proximity ligation assay on hamsters samples (fig 3d). Mol Cell Biol (2016) ncbi |
Cell Signaling Technology
rabbit polyclonal |
| Cell Signaling Technology Araf antibody (Cell Signaling, 4432) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi |
rabbit polyclonal |
| In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology Araf antibody (CST, 4431) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi |
rabbit polyclonal |
| In order to assess the effects of LY3009120, a panRAF and RAF dimer inhibitor, in human models of colorectal cancer, Cell Signaling Technology Araf antibody (Cell Signaling, 4432) was used in western blot on human samples (fig 4a). Oncotarget (2017) ncbi |
rabbit polyclonal |
| Cell Signaling Technology Araf antibody (Cell Signaling, 4431) was used in western blot on human samples at 1:500 (fig 3b). Am J Physiol Lung Cell Mol Physiol (2016) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments